CEREBROTENDINOUS XANTHOMATOSIS: HEARD OF IT?

  • Sankalp Senior Resident, Department of General Surgery, Kasturba Medical College, Manipal University, Manipal, India
  • Rajesh Parameshwaran Nair Registrar, Department of Neurosurgery, Kasturba Medical College, Manipal University, Manipal, India
  • Bhavna Nayal Department of Pathology, Kasturba Medical College, Manipal University, Manipal
Keywords: mental retardation, soft tissue swellings, autosomal recessive disorder

Abstract

Cerebrotendinous Xanthomatosis (CTX) is a rare, autosomal recessive, lipid storage disorder, characterized by the accumulation of cholesterol and cholestanol, predominantly in the brain, spinal cord, peripheral nerves, tendons, lungs, liver, and kidneys. The usual conundrum is an amalgam of the primary symptom, as mentioned above, along with features of cerebellar ataxia, juvenile cataract, and subcutaneous swellings over tendons. Mental retardation is a very striking and prominent feature in this syndrome. Prompt diagnosis is vital, as patients benefit from therapy with chenodeoxycholic acid and the progress of the disease can be halted prior to irreversible neurological dysfunction. This is our experience.

Downloads

Download data is not yet available.

References

1. Kuriyama M, Fujiyama J, Yoshidome H, et al. Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of 8 patients and review of the literature. J Neurol Sci. 1991;102:225-32.
2. Lee Y, Lin PY, Chin NM, Chang WN, Wen JK. Cerebrotendinous Xanthomatosis with psychiatric disorders: Report of three siblings and literature review. Chang Gung Med J.2002;25:334-40.
3. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311:1669-1652.
How to Cite
1.
Sankalp, Nair RP, Nayal B. CEREBROTENDINOUS XANTHOMATOSIS: HEARD OF IT?. Med. res. chronicles [Internet]. 2015Mar.15 [cited 2024Nov.22];2(2):170-2. Available from: https://medrech.com/index.php/medrech/article/view/65
Section
Case Study